VH4127 is a cyclic peptide designed to target low-density lipoprotein receptors (LDLR) with a KD of 18 nM for hLDLR. Incorporating non-natural amino acid residues, VH4127 binds specifically to epidermal growth factor (EGF) LDLR homologous domains in both rodents and humans.
Molecular Weight:
1048.37
Formula:
C41H73N15O9S4
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
